UK Faces Distribution Challenges With Pfizer/BioNTech Vaccine
Regulator Issues Guidance As First Consignment Arrives From Belgium
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
You may also be interested in...
The UK MHRA has crunched the safety and effectiveness data on the Pfizer/BioNTech COVID-19 vaccine and permitted its use by even more people.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.